dbCRAF: a curated knowledgebase for regulation of radiation response in human cancer.
Jie LiuJing LiFangfang JinQian LiGuoping ZhaoLijun WuXiaoyan LiJun-Feng XiaNa ChengPublished in: NAR cancer (2024)
Radiation therapy (RT) is one of the primary treatment modalities of cancer, with 40-60% of cancer patients benefiting from RT during their treatment course. The intrinsic radiosensitivity or acquired radioresistance of tumor cells would affect the response to RT and clinical outcomes in patients. Thus, mining the regulatory mechanisms in tumor radiosensitivity or radioresistance that have been verified by biological experiments and computational analysis methods will enhance the overall understanding of RT. Here, we describe a comprehensive database dbCRAF (http://dbCRAF.xialab.info/) to document and annotate the factors (1,677 genes, 49 proteins and 612 radiosensitizers) linked with radiation response, including radiosensitivity, radioresistance in cancer cells and prognosis in cancer patients receiving RT. On the one hand, dbCRAF enables researchers to directly access knowledge for regulation of radiation response in human cancer buried in the vast literature. On the other hand, dbCRAF provides four flexible modules to analyze and visualize the functional relationship between these factors and clinical outcome, KEGG pathway and target genes. In conclusion, dbCRAF serves as a valuable resource for elucidating the regulatory mechanisms of radiation response in human cancers as well as for the improvement of RT options.
Keyphrases
- papillary thyroid
- endothelial cells
- radiation therapy
- squamous cell
- end stage renal disease
- healthcare
- radiation induced
- chronic kidney disease
- genome wide
- systematic review
- newly diagnosed
- squamous cell carcinoma
- emergency department
- dna damage response
- ejection fraction
- gene expression
- childhood cancer
- dna damage
- peritoneal dialysis
- dna methylation
- adverse drug
- smoking cessation
- bioinformatics analysis
- rectal cancer